Privi Speciality Chemicals Limited — Important, 29-11-2024: Updates

The Board of Directors at Privispeciality Chemicals has approved the "Privi Employee Stock Option Scheme 2024" (Privi ESOS 2024), allowing the grant of options for up to 78,125 equity shares. This represents 2% of the paid-up equity share capital and is directed towards eligible employees at the company's discretion.

The options will have a maximum exercise period of five years following their vesting, which will occur no sooner than one year post-grant. The exercise price will be determined by the Nomination and Remuneration Committee, adhering to relevant accounting policies and ensuring it is at least equal to the share's face value of Rs. 10.

The scheme aligns with the company's strategic goals of incentivizing and retaining talent, which suggests a positive outlook on workforce engagement. Shareholder approval will be required for the scheme's implementation, indicating a step towards further enhancing company performance through employee motivation.